873054-97-8 Usage
Uses
Used in Pharmaceutical Industry:
4-Hydroxy-5-methoxyquinoline-3-carboxylic acid is used as a pharmaceutical agent for its anti-inflammatory and antioxidant properties. Its ability to reduce inflammation and oxidative stress makes it a promising candidate for the development of new drugs to treat various diseases and conditions.
Used in Coordination Chemistry:
4-Hydroxy-5-methoxyquinoline-3-carboxylic acid is used as a chelating agent in metal ion coordination chemistry. Its ability to form stable complexes with metal ions can be utilized in various applications, such as the development of new materials with unique properties or the removal of toxic metal ions from the environment.
Used in Chemical Synthesis:
4-Hydroxy-5-methoxyquinoline-3-carboxylic acid is used as a building block for the synthesis of other chemical compounds with potential biological activities. Its versatile structure allows for the development of new compounds with a range of therapeutic applications, contributing to the advancement of medicine and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 873054-97-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,0,5 and 4 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 873054-97:
(8*8)+(7*7)+(6*3)+(5*0)+(4*5)+(3*4)+(2*9)+(1*7)=188
188 % 10 = 8
So 873054-97-8 is a valid CAS Registry Number.
InChI:InChI=1/C11H9NO4/c1-16-8-4-2-3-7-9(8)10(13)6(5-12-7)11(14)15/h2-5H,1H3,(H,12,13)(H,14,15)
873054-97-8Relevant academic research and scientific papers
Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
-
Paragraph 0359, (2015/09/22)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
-
, (2012/12/14)
The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES
-
, (2012/04/23)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
